共 23 条
- [1] COMPREHENSIVE COMPARATIVE EFFECTIVENESS AND SAFETY OF FIRST-LINE CALCIUM CHANNEL BLOCKER MONOTHERAPY IN HYPERTENSIVE PATIENTS: A LARGE-SCALE MULTINATIONAL PARTICIPANT-LEVEL ASSESSMENTJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1583 - 1583Lu, YuanKhera, RohanLiu, YuntianChen, RuijunSchuemie, MartijnHripcsak, GeorgeSuchard, MarcKrumholz, Harlan M.
- [2] Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysisLANCET, 2019, 394 (10211): : 1816 - 1826Suchard, Marc A.Schuemie, Martijn J.Krumholz, Harlan M.You, Seng ChanChen, RuiJunPratt, NicoleReich, Christian G.Duke, JonMadigan, DavidHripcsak, GeorgeRyan, Patrick B.
- [3] Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients A Large-Scale Multicenter Observational StudyHYPERTENSION, 2021, 77 (05) : 1528 - 1538You, Seng ChanKrumholz, Harlan M.Suchard, Marc A.Schuemie, Martijn J.Hripcsak, GeorgeChen, RuiJunShea, StevenDuke, JonPratt, NicoleReich, Christian G.Madigan, DavidRyan, Patrick B.Park, Rae WoongPark, Sungha
- [4] COMPARATIVE CARDIOVASCULAR EFFECTIVENESS AND SAFETY OF INDIVIDUAL ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: A MULTINATIONAL PARTICIPANT-LEVEL ASSESSMENT FROM LEGEND-HTNJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1474 - 1474Khera, RohanLu, YuanChen, RuijunSchuemie, MartijnHripcsak, GeorgeKrumholz, HarlanSuchard, Marc
- [5] Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers A Multinational Cohort StudyHYPERTENSION, 2021, 78 (03) : 591 - 603Chen, RuiJunSuchard, Marc A.Krumholz, Harlan M.Schuemie, Martijn J.Shea, StevenDuke, JonPratt, NicoleReich, Christian G.Madigan, DavidYou, Seng ChanRyan, Patrick B.Hripcsak, George
- [6] FIRST-LINE TREATMENT PATTERNS IN PATIENTS WITH INSOMNIA: A LARGE-SCALE, REAL-WORLD COHORT STUDYSLEEP, 2022, 45 : A204 - A204Grandner, MichaelAhuja, AjayMeijer, PaulienBusser, AlexanderMcCall, WilliamLettieri, Christopher
- [7] Large-scale multinational trends in the use of cardioprotective antihyperglycemic agents as first-line therapy in patients with type 2 diabetes and cardiovascular disease: a LEGEND-T2DM studyCIRCULATION, 2024, 150Thangaraj, PhyllisAminorroaya, AryaDhingra, LovedeepCamargos, Aline PedrosoZhou, JinBlacketer, ClairBu, FanChai, YiChattopadhyay, ShounakDorr, DavidDuarte-Salles, TalitaLau, WallisLiu, YuntianLu, YuanMan, KennethMinty, EvanRichter, LaurenRoss, JosephShah, Nigam
- [8] Comparative Effectiveness and Cost of Adding Rituximab to First-Line Chemotherapy for Elderly Patients Diagnosed With Diffuse Large B-Cell LymphomaCANCER, 2012, 118 (24) : 6079 - 6088Griffiths, Robert I.Gleeson, Michelle L.Mikhael, JosephDreyling, Martin H.Danese, Mark D.
- [9] Clinical effectiveness and safety of first-line biologic vedolizumab as a monotherapy or combination therapy in ulcerative colitis and Crohn's disease patients: results from the EVOLVE studyJOURNAL OF CROHNS & COLITIS, 2020, 14 : S381 - S382Bressler, B.Yarur, A.Kopylov, U.Bassel, M.Brett, N.Colby, C.Lopez, C.Saha, S.Kifnidi, C.Agboton, C.Adsul, S.Demuth, D.Luo, M.Wang, S.Mantzaris, G. J.
- [10] CLINICAL EFFECTIVENESS AND SAFETY OF FIRST-LINE BIOLOGIC VEDOLIZUMAB AS A MONOTHERAPY OR COMBINATION THERAPY IN ULCERATIVE COLITIS AND CROHN'S DISEASE PATIENTS: RESULTS FROM THE EVOLVE STUDYGASTROENTEROLOGY, 2020, 158 (06) : S407 - S407Bressler, BrianYarur, Andres J.Kopylov, UriBassel, MarielleBrett, Neil R.Colby, ChrisLopez, ClaudiaSaha, SumitKifnidi, ChristinaAgboton, ChristianAdsul, ShashiDemuth, DirkLuo, MichelleWang, SongMantzaris, Gerassimos J.